Monday, April 2, 2007

Glaxo says FDA OKs new dosing schedule for hepatitis vaccine

(Reuters) - The Europe's biggest drugmaker said the accelerated dosing schedule consists of three doses given within three weeks followed by a booster dose at 12 months.




Read more at Reuters.com Government Filings News

No comments: